Consolidation osimertinib for unresectable stage III epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer: redefining standard care
@article{TLCR92194, author = {Fang Wu and Yue Zeng and Joel W. Neal}, title = {Consolidation osimertinib for unresectable stage III epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer: redefining standard care}, journal = {Translational Lung Cancer Research}, volume = {13}, number = {10}, year = {2024}, keywords = {}, abstract = {}, issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/92194} }